Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Open forum infectious diseases(2023)
摘要
DOR/3TC/TDF is a well-tolerated option for nonoccupational PEP. NCT04233372.
更多查看译文
关键词
doravirine/lamivudine/tenofovir disoproxil fumarate,prophylaxis,doravipep,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要